[Clinical research on the anti-asthenic, anti-anorexic and detoxicating action of an association of glycuronamide, vitamin C and caffeine in various morbid conditions].
D000328:Adult; D000368:Aged; D000747:Anemia, Hypochromic / Q000188:drug therapy*; D000856:Anorexia Nervosa / Q000188:drug therapy*; D001205:Ascorbic Acid / Q000627:therapeutic use*; D001247:Asthenia / Q000188:drug therapy*; D001660:Biliary Tract Diseases / Q000188:drug therapy*; D002110:Caffeine / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005965:Glucuronates / Q000627:therapeutic use*; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000188:drug therapy*; D010998:Pleurisy / Q000188:drug therapy*; D014435:Typhoid Fever / Q000188:drug therapy*
D005965:Glucuronates; D002110:Caffeine; D001205:Ascorbic Acid
Ricerche cliniche sull'azione antiastenica, antianoressica e disintossicante di una associazione glicuronamide-vitamina C-caffeina in varie affezioni morbose.